Thomas Frodl, MD
- 3Articles
- 12.3KReads
- 2004–2010Active
- 26Collaborators
- 58Citations
About
Thomas Frodl, MD, has contributed to research on major depressive disorder (MDD), focusing on brain activation differences associated with antidepressants such as mirtazapine and venlafaxine. His work includes studies on predicting clinical response to serotonergic and noradrenergic antidepressants using auditory evoked potentials, as well as longitudinal analyses of hippocampal and amygdala changes in patients with MDD. Frodl's publications, spanning from 2004 to 2010, often involved collaboration with co-authors including Hans-Jürgen Möller and Arun L. W. Bokde.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
